111 related articles for article (PubMed ID: 9922073)
1. Defective regulation of leukemic hematopoiesis in chronic myeloid leukemia.
Eaves C; Cashman J; Eaves A
Leuk Res; 1998 Dec; 22(12):1085-96. PubMed ID: 9922073
[TBL] [Abstract][Full Text] [Related]
2. Granulocyte-macrophage colony-stimulating factor modulation of the inhibitory effect of transforming growth factor-beta on normal and leukemic human hematopoietic progenitor cells.
Cashman JD; Eaves AC; Eaves CJ
Leukemia; 1992 Sep; 6(9):886-92. PubMed ID: 1518302
[TBL] [Abstract][Full Text] [Related]
3. The biology of normal and neoplastic stem cells in CML.
Eaves C; Udomsakdi C; Cashman J; Barnett M; Eaves A
Leuk Lymphoma; 1993; 11 Suppl 1():245-53. PubMed ID: 8251904
[TBL] [Abstract][Full Text] [Related]
4. Characterization and selection of benign stem cells in chronic myeloid leukemia.
Lemoli RM
Haematologica; 1993; 78(6):393-400. PubMed ID: 8175034
[TBL] [Abstract][Full Text] [Related]
5. Bestatin selectively suppresses the growth of leukemic stem/progenitor cells with BCR/ABL mRNA transcript in patients with chronic myelogeneous leukemia.
Fujisaki T; Otsuka T; Gondo H; Okamura T; Niho Y; Ohhinata A; Abe F
Int Immunopharmacol; 2003 Jun; 3(6):901-7. PubMed ID: 12781706
[TBL] [Abstract][Full Text] [Related]
6. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
[TBL] [Abstract][Full Text] [Related]
7. Elucidating critical mechanisms of deregulated stem cell turnover in the chronic phase of chronic myeloid leukemia.
Holyoake TL; Jiang X; Drummond MW; Eaves AC; Eaves CJ
Leukemia; 2002 Apr; 16(4):549-58. PubMed ID: 11960331
[TBL] [Abstract][Full Text] [Related]
8. Linkage of proliferative and maturational abnormalities in chronic myelogenous leukemia and relevance to treatment.
Clarkson B; Strife A
Leukemia; 1993 Nov; 7(11):1683-721. PubMed ID: 8231240
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology of CML: do defects in integrin function contribute to the premature circulation and massive expansion of the BCR/ABL positive clone?
Verfaillie CM; Hurley R; Zhao RC; Prosper F; Delforge M; Bhatia R
J Lab Clin Med; 1997 Jun; 129(6):584-91. PubMed ID: 9178724
[TBL] [Abstract][Full Text] [Related]
10. Rapid decline of chronic myeloid leukemic cells in long-term culture due to a defect at the leukemic stem cell level.
Udomsakdi C; Eaves CJ; Swolin B; Reid DS; Barnett MJ; Eaves AC
Proc Natl Acad Sci U S A; 1992 Jul; 89(13):6192-6. PubMed ID: 1631107
[TBL] [Abstract][Full Text] [Related]
11. New models to investigate mechanisms of disease genesis from primitive BCR-ABL(+) hematopoietic cells.
Eaves C; Jiang X; Eisterer W; Chalandon Y; Porada G; Zanjani E; Eaves A
Ann N Y Acad Sci; 2003 May; 996():1-9. PubMed ID: 12799276
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic stem cells in chronic myeloid leukemia.
Petzer AL; Gunsilius E
Arch Med Res; 2003; 34(6):496-506. PubMed ID: 14734089
[TBL] [Abstract][Full Text] [Related]
13. Cytokinetic considerations relevant to development of a successful therapeutic strategy in chronic myelogenous leukemia (CML).
Clarkson B; Strife A
Leuk Lymphoma; 1993; 11 Suppl 1():101-7. PubMed ID: 8251883
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of hematopoiesis in bone marrow cultures from patients with chronic myeloid leukemia: effect of recombinant cytokines in dexter-type long-term cultures.
Luna-Bautista F; Sánchez-Valle E; Ayala-Sánchez M; Morales-Polanco M; Meillon-García L; Benítez-Bribiesca L; Mayani H
Hematology; 2003 Jun; 8(3):155-63. PubMed ID: 12745649
[TBL] [Abstract][Full Text] [Related]
15. Global dynamics of hematopoietic stem cells and differentiated cells in a chronic myeloid leukemia model.
Aïnseba B; Benosman C
J Math Biol; 2011 Jun; 62(6):975-97. PubMed ID: 20717678
[TBL] [Abstract][Full Text] [Related]
16. Integrin-mediated regulation of hematopoiesis: do BCR/ABL-induced defects in integrin function underlie the abnormal circulation and proliferation of CML progenitors?
Verfaillie CM; Hurley R; Lundell BI; Zhao C; Bhatia R
Acta Haematol; 1997; 97(1-2):40-52. PubMed ID: 8980609
[TBL] [Abstract][Full Text] [Related]
17. Do endothelial cells belong to the primitive stem leukemic clone in CML? Role of extracellular vesicles.
Ramos TL; Sánchez-Abarca LI; López-Ruano G; Muntión S; Preciado S; Hernández-Ruano M; Rosado B; de las Heras N; Chillón MC; Hernández-Hernández Á; González M; Sánchez-Guijo F; Del Cañizo C
Leuk Res; 2015 Aug; 39(8):921-4. PubMed ID: 26105049
[TBL] [Abstract][Full Text] [Related]
18. Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies.
Clarkson B; Strife A; Wisniewski D; Lambek CL; Liu C
Leukemia; 2003 Jul; 17(7):1211-62. PubMed ID: 12835715
[TBL] [Abstract][Full Text] [Related]
19. Role of SPA-1 in phenotypes of chronic myelogenous leukemia induced by BCR-ABL-expressing hematopoietic progenitors in a mouse model.
Kometani K; Aoki M; Kawamata S; Shinozuka Y; Era T; Taniwaki M; Hattori M; Minato N
Cancer Res; 2006 Oct; 66(20):9967-76. PubMed ID: 17047059
[TBL] [Abstract][Full Text] [Related]
20. The BCR/ABL transgene causes abnormal NK cell differentiation and can be found in circulating NK cells of advanced phase chronic myelogenous leukemia patients.
Nakajima H; Zhao R; Lund TC; Ward J; Dolan M; Hirsch B; Miller JS
J Immunol; 2002 Jan; 168(2):643-50. PubMed ID: 11777957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
